Literature DB >> 7664027

Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat.

L A Pini1, M Sandrini, G Vitale.   

Abstract

The pain-threshold in the hot-plate test and serotonin (5-HT) receptor binding capacity in the cortex and pontine areas of rat brain were studied after intraperitoneal (ip) administration of acetyl salicylate of lysine equivalent to 400 mg/kg of acetylsalicylic acid (ASA). The antinociceptive activity of ASA was prevented by ip pre-treatment with Parachlorophenylalanine (PCPA) at the rate of 100 mg/kg/day for 4 days. PCPA pre-treatment increased the number of 5-HT receptors and abolished the ASA-induced reduction in 5-HT receptor binding capacity in the cortex but did not affect serum salicylate levels. These results provide support for the hypothesis that the antinociceptive action of ASA, at least in the hot-plate test, involves the central serotonergic system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664027     DOI: 10.1007/bf01630485

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  30 in total

1.  The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rat.

Authors:  V Chapman; A H Dickenson
Journal:  Eur J Pharmacol       Date:  1992-09-04       Impact factor: 4.432

2.  Hypothalamic monoaminergic mechanisms of aspirin-induced analgesia in monkeys.

Authors:  K W Shyu; M T Lin
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

3.  A modified hot-plate test sensitive to mild analgesics.

Authors:  S Hunskaar; O G Berge; K Hole
Journal:  Behav Brain Res       Date:  1986-08       Impact factor: 3.332

4.  Effects of anti-inflammatory drugs on rat hind-paw swelling caused by phospholipase A2 from Naja naja atra venom.

Authors:  J P Wang; C M Teng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

5.  Opiate and serotonergic mechanisms of stimulation-produced analgesia within the periaqueductal gray.

Authors:  D S Nichols; B E Thorn; G G Berntson
Journal:  Brain Res Bull       Date:  1989-04       Impact factor: 4.077

6.  Electrical stimulation of the gastrocnemius muscle in the spontaneously hypertensive rat increases the pain threshold: role of different serotonergic receptors.

Authors:  P Hoffmann; J O Skarphedinsson; M Delle; P Thorén
Journal:  Acta Physiol Scand       Date:  1990-02

7.  Intracerebroventricular micro-injections of non-steroidal anti-inflammatory drugs abolish reperfusion hyperalgesia in the rat's tail.

Authors:  Linda Gelgor; Steven Cartmell; Duncan Mitchell
Journal:  Pain       Date:  1992-09       Impact factor: 6.961

8.  Prediction of human analgesic dosages of nonsteroidal anti-inflammatory drugs (NSAIDs) from analgesic ED50 values in mice.

Authors:  S F Pong; S M Demuth; C M Kinney; P Deegan
Journal:  Arch Int Pharmacodyn Ther       Date:  1985-02

9.  Effect of aspirin on serotonin and met-enkephalin in brain: correlation with the antinociceptive activity of the drug.

Authors:  A Groppetti; P C Braga; G Biella; M Parenti; L Rusconi; P Mantegazza
Journal:  Neuropharmacology       Date:  1988-05       Impact factor: 5.250

10.  Dissociation between antinociceptive and anti-inflammatory effects of acetylsalicylic acid and indomethacin in the formalin test.

Authors:  Steinar Hunskaar; Odd-Geir Berge; Kjell Hole
Journal:  Pain       Date:  1986-04       Impact factor: 6.961

View more
  2 in total

1.  Enhancement of antinociception by coadministration of minocycline and a non-steroidal anti-inflammatory drug indomethacin in naïve mice and murine models of LPS-induced thermal hyperalgesia and monoarthritis.

Authors:  Ala'a Ahmed Abu-Ghefreh; Willias Masocha
Journal:  BMC Musculoskelet Disord       Date:  2010-12-01       Impact factor: 2.362

2.  Study on the Antinociceptive Effects of Herba Epimedium in Mice.

Authors:  Jiang-Hong Sun; Xin-Jie Ruan; Li-Na Wang; Shuang Liang; Xin-Ping Li
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-11       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.